Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 1:49 PM UTC
| NCT Number | NCT07755436 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 180 participants |
| Active Locations | 2 sites in the US |
| Sponsor | ArriVent BioPharma, Inc. |
| Last Updated on CT.gov | August 10, 2026 (3 weeks ago) |
As of September 1, 2026: Clinical trial NCT07755436 is currently recruiting participants. This phase1 study for ovarian cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by ArriVent BioPharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07755436 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07755436 was last updated 3 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.